Norway Offshore Oil Workers Reach Wage Deal, Averting Strike 
BHP Workers Approve New Labour Agreement at WA Iron Ore Operations 
DOJ Seeks Dismissal of Fraud Charges Against Gautam Adani in U.S. Court 
Northern Star Appoints New CEO as Activist Elliott Pushes for Leadership Overhaul 
Sodexo Raises 2026 Revenue Outlook After Strong Q3 Sales Beat 
OpenAI Proposes 5% U.S. Government Stake Amid AI Policy Talks 
Super Micro Employees Detained in Taiwan AI Server Export Investigation 
Kioxia Bets on AI Memory Boom With Next-Gen NAND Production in Japan 
Samsung Q2 Profit Seen Soaring as AI Memory Demand Keeps Chip Prices Elevated 
Foxconn Q2 Revenue Surges Nearly 40% on Strong AI Server Demand 
Meta CEO Zuckerberg Says AI Agent Development Has Slowed Despite Massive AI Investment 
Meta Cloud Ambitions Could Challenge AWS, Azure, and Google Cloud, Says Morgan Stanley 
Anthropic Tightens AI Access Controls After Reports of China-Based Workarounds 
EU Chip Industry Faces Growing Risks From China Export Controls and U.S. Technology Dependence: Report 
Suncorp Cuts 2026 Premium Growth Forecast as Australia, New Zealand Markets Weaken 
Lockheed Martin Emerges as Frontrunner to Acquire Ultra Maritime in $3.5 Billion Defense Deal 
SK Telecom Co. has released a mobile app-based DNA testing service dubbed care8 DNA in partnership with its joint venture Invites Healthcare Co. and bio firm Macrogen Inc.
The subscription-based setting allows users to sign up for 29 types of genetic testing, such as for nicotine reliance and hair loss.
Users will receive DNA test kits at home, which they would send back to SK Telecom with their saliva for analysis.
Test results will be available on the care8 DNA app after two weeks.
According to SK Telecom, their DNA service, which costs 99,000 won for a one-year subscription, is more affordable than local direct-to-consumer (DTC) genetic tests.
The app also provides other services, such as personalized health coaching. More genetic tests would also be introduced.
SK Telecom, South Korea's largest mobile carrier, increased its investment in Israel-based startup Nano-X Imaging Ltd in June to boost its presence in the digital health care sector.
The global DTC genetic testing market is expected to increase to $6.4 billion in 2028 from $824 million in 2018.
